• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Validation and Refinement of the Baveno VI Criteria for Ruling Out High-Risk Varices.巴弗诺VI标准排除高危静脉曲张的验证与细化
Gastroenterol Res Pract. 2020 Nov 27;2020:4217512. doi: 10.1155/2020/4217512. eCollection 2020.
2
A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.基于脾脏硬度测量和 Baveno VI 标准的联合模型排除晚期慢性肝病高危静脉曲张。
J Hepatol. 2018 Aug;69(2):308-317. doi: 10.1016/j.jhep.2018.04.023. Epub 2018 May 3.
3
Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.Baveno VI 标准和脾脏硬度测量可排除病毒抑制的乙型肝炎病毒相关肝硬化中的高危静脉曲张。
J Hepatol. 2021 Mar;74(3):584-592. doi: 10.1016/j.jhep.2020.09.034. Epub 2020 Oct 8.
4
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.非酒精性脂肪性肝病肝硬化通过硬度和血小板对食管静脉曲张的无创预测。
J Hepatol. 2018 Oct;69(4):878-885. doi: 10.1016/j.jhep.2018.05.019. Epub 2018 May 24.
5
Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.在不符合 Baveno VI 标准的患者中,通过肝硬度和血清标志物来排除高危静脉曲张。
World J Gastroenterol. 2019 Sep 21;25(35):5323-5333. doi: 10.3748/wjg.v25.i35.5323.
6
Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.验证原始、扩展的 Baveno VI 标准以及逐步和血小板-MELD 标准,以排除各种病因导致的代偿性肝硬化中需要治疗的静脉曲张。
Ann Hepatol. 2020 Mar-Apr;19(2):209-213. doi: 10.1016/j.aohep.2019.08.005. Epub 2019 Sep 25.
7
Validation of the Baveno VI criteria to rule out high-risk varices using hepatic shear-wave elastography.使用肝脏剪切波弹性成像技术验证巴韦诺VI标准以排除高危静脉曲张
Eur J Gastroenterol Hepatol. 2023 May 1;35(5):559-567. doi: 10.1097/MEG.0000000000002507. Epub 2023 Mar 18.
8
Liver stiffness by two-dimensional shear wave elastography for screening high-risk varices in patients with compensated advanced chronic liver disease.二维剪切波弹性成像检测肝硬度在代偿期慢性肝病进展期高危静脉曲张筛查中的应用
Eur Radiol. 2022 Mar;32(3):2078-2088. doi: 10.1007/s00330-021-08280-3. Epub 2021 Oct 29.
9
Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease.肝硬度和血小板预测人类免疫缺陷病毒感染和代偿期晚期慢性肝病患者的食管静脉曲张。
Clin Infect Dis. 2020 Dec 31;71(11):2810-2817. doi: 10.1093/cid/ciz1181.
10
Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.验证 Baveno VI 标准以识别低风险肝硬化患者,这些患者无需进行静脉曲张内镜监测。
J Hepatol. 2016 Nov;65(5):899-905. doi: 10.1016/j.jhep.2016.06.021. Epub 2016 Jul 5.

引用本文的文献

1
The Prediction and Treatment of Bleeding Esophageal Varices in the Artificial Intelligence Era: A Review.人工智能时代食管静脉曲张出血的预测与治疗:综述
Cureus. 2024 Mar 8;16(3):e55786. doi: 10.7759/cureus.55786. eCollection 2024 Mar.
2
Baveno VII Criteria Is an Accurate Risk Stratification Tool to Predict High-Risk Varices Requiring Intervention and Hepatic Events in Patients with Advanced Hepatocellular Carcinoma.巴韦诺 VII 标准是一种准确的风险分层工具,可用于预测晚期肝细胞癌患者中需要干预的高危静脉曲张和肝脏事件。
Cancers (Basel). 2023 Apr 26;15(9):2480. doi: 10.3390/cancers15092480.
3
VariScreen secures the screening of high-risk varices in patients with hepatitis B virus-related cirrhosis beyond Baveno VI criteria.VariScreen可对超出巴韦诺VI标准的乙型肝炎病毒相关性肝硬化患者的高危静脉曲张进行筛查。
Front Physiol. 2022 Sep 27;13:1006657. doi: 10.3389/fphys.2022.1006657. eCollection 2022.
4
Ultrasonic spleen thickness-based indexes surpass Baveno VI criteria in high-risk gastroesophageal varices detection.基于超声脾脏厚度的指标在高危胃食管静脉曲张检测中优于 Baveno VI 标准。
Hepatol Int. 2022 Jun;16(3):649-657. doi: 10.1007/s12072-022-10327-6. Epub 2022 Apr 12.

本文引用的文献

1
Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort.巴韦诺VI标准和扩展的巴韦诺VI标准成功预测了智利队列中无高危胃食管静脉曲张。
Liver Int. 2020 Jun;40(6):1427-1434. doi: 10.1111/liv.14373. Epub 2020 Jan 22.
2
Validating and expanding the Baveno VI criteria for esophageal varices in patients with advanced liver disease: a multicenter study.验证并扩展晚期肝病患者食管静脉曲张的巴韦诺VI标准:一项多中心研究。
Ann Gastroenterol. 2020 Jan-Feb;33(1):87-94. doi: 10.20524/aog.2019.0429. Epub 2019 Oct 23.
3
Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.验证原始、扩展的 Baveno VI 标准以及逐步和血小板-MELD 标准,以排除各种病因导致的代偿性肝硬化中需要治疗的静脉曲张。
Ann Hepatol. 2020 Mar-Apr;19(2):209-213. doi: 10.1016/j.aohep.2019.08.005. Epub 2019 Sep 25.
4
Portal Hypertension: Pathogenesis and Diagnosis.门静脉高压症:发病机制与诊断。
Clin Liver Dis. 2019 Nov;23(4):573-587. doi: 10.1016/j.cld.2019.07.007.
5
Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.在不符合 Baveno VI 标准的患者中,通过肝硬度和血清标志物来排除高危静脉曲张。
World J Gastroenterol. 2019 Sep 21;25(35):5323-5333. doi: 10.3748/wjg.v25.i35.5323.
6
Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV-cirrhotic patients.直接抗病毒药物持续病毒学应答对 HCV 肝硬化患者胃食管静脉曲张和 Baveno 标准的影响。
J Gastroenterol. 2020 Feb;55(2):205-216. doi: 10.1007/s00535-019-01619-0. Epub 2019 Sep 6.
7
Baveno Criteria Safely Identify Patients With Compensated Advanced Chronic Liver Disease Who Can Avoid Variceal Screening Endoscopy: A Diagnostic Test Accuracy Meta-Analysis.巴韦诺标准可安全识别代偿期晚期慢性肝病患者,这些患者可避免静脉曲张筛查内镜检查:一项诊断试验准确性的荟萃分析。
Front Physiol. 2019 Aug 13;10:1028. doi: 10.3389/fphys.2019.01028. eCollection 2019.
8
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices.FibroScan® 新型脾脏硬度测量可改善高危食管静脉曲张的筛查。
Liver Int. 2020 Jan;40(1):175-185. doi: 10.1111/liv.14228. Epub 2019 Sep 11.
9
Beyond Baveno VI: How far are we?超越巴韦诺 VI:我们进展到哪一步了?
Dig Liver Dis. 2019 Aug;51(8):1141-1143. doi: 10.1016/j.dld.2019.06.014. Epub 2019 Jul 23.
10
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience.瞬时弹性成像技术在高危静脉曲张的非侵入性评估中是否必要?REAL 经验。
Am J Gastroenterol. 2019 Aug;114(8):1275-1282. doi: 10.14309/ajg.0000000000000266.

巴弗诺VI标准排除高危静脉曲张的验证与细化

Validation and Refinement of the Baveno VI Criteria for Ruling Out High-Risk Varices.

作者信息

Zhou Hong, Hu Han, Tian Maoyong, Chu Jun, Tian Caiyun, Yang Yanqing, Lin Shide

机构信息

Department of Infectious Diseases, Affiliated Hospital of Zunyi Medical University, 201 Dalian Street, Guizhou 563003, China.

Department of Infectious Diseases, Suining Central Hospital, 127 Desheng Street, Suining, Sichuan 629000, China.

出版信息

Gastroenterol Res Pract. 2020 Nov 27;2020:4217512. doi: 10.1155/2020/4217512. eCollection 2020.

DOI:10.1155/2020/4217512
PMID:33376483
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7744238/
Abstract

In the past decade, numerous studies have evaluated the roles of noninvasive methods for diagnosing or excluding varices and high-risk varices in patients with liver cirrhosis. The Baveno VI criteria recommend the use of a simple algorithm based on a liver stiffness measurement < 20 kPa through transient elastography and a platelet count > 150 × 10/L for ruling out high-risk varices in patients with compensated advanced chronic liver disease. A large number of studies have validated the clinical usefulness of Baveno VI criteria for excluding high-risk varices. Several strategies have been proposed to refine the Baveno VI criteria; however, currently there is no review to summarize the diagnostic accuracy and limitations of the Baveno VI criteria after extensive validation. In this review, we summarize the diagnostic accuracy and limitations of the Baveno VI criteria after extensive validation. We also discuss methods to refine these criteria.

摘要

在过去十年中,众多研究评估了非侵入性方法在诊断或排除肝硬化患者静脉曲张及高危静脉曲张方面的作用。《巴韦诺VI标准》推荐使用一种简单算法,即通过瞬时弹性成像法测得肝脏硬度值<20 kPa且血小板计数>150×10⁹/L,以排除代偿期晚期慢性肝病患者的高危静脉曲张。大量研究证实了《巴韦诺VI标准》在排除高危静脉曲张方面的临床实用性。已提出多种策略来完善《巴韦诺VI标准》;然而,目前尚无综述总结经过广泛验证后的《巴韦诺VI标准》的诊断准确性及局限性。在本综述中,我们总结了经过广泛验证后的《巴韦诺VI标准》的诊断准确性及局限性。我们还讨论了完善这些标准的方法。